Prevention of kidney disease and long-term survival
著者
書誌事項
Prevention of kidney disease and long-term survival
Plenum Medical Book Co., c1982
大学図書館所蔵 全3件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and indexes
内容説明・目次
内容説明
Renal Failure Prevention and Treatment in the 19808 It appears logical to juxtapose in this volume prevention-low cost and nonmorbid-with uremia therapy, which is very morbid and very high cost. Treated uremic patients constitute an important, complex, and demanding group of survivors of a formerly universally fatal disease. Throughout the developed nations of the world, an increasing fraction of the health care budget is devoted to sustaining lives by dialytic therapy and renal transplantation. In the United States, for example, patients in renal failure comprise 0.2% of those eligible for support by Medicare, but consume 5.0% of the Medicare budget. Economic stresses in funding kidney patients have, in some countries such as Great Britain, forced a return to restrictive selection policies abhorrent to empathetic physicians. For third world residents, attention to nutrition, sanitation, and infections such as malaria must take a higher priority than costly uremia therapy. Thus the solution of one problem (retarding death from uremia) created several equally vexing other dilemmas (who should be treated and at what cost?).
While sociologists, economists, and ethicists struggle with the new field of psychonephrology,1 a group of investigators and clinicians convened to examine medical aspects of long-surviving treated uremic patients. These proceedings represent the first American analyis of those unique patients who have lived for ten or more years beyond what would have formerly been certain death in uremia.
目次
I. Nutrition and Divalent Ion in Retarding Progression.- 1. Low-Protein Diets and the Nondialyzed Uremic Patient.- 2. Delay of Progression of Renal Failure.- 3. Phosphate and Prevention of Renal Failure.- 4. Improvement of Acidosis in Long-Term Dietary Treatment of Chronic Renal Failure.- II. Glomerular Damage and Its Prevention.- 5. Hyperfiltration as a Major Causative Factor in Initiation and Progression of Glomerulosclerosis.- 6. Aggravation of Glomerulonephritis by Hypertension.- III. Genesis and Prevention of Diabetic Nephropathy: New Concepts.- 7. Relationship Between Hyperglycemia and Diabetic Glomerulosclerosis.- 8. The Role of Hemodynamic Alterations in the Pathogenesis of Diabetic Glomerulopathy.- IV. Use and Misuse of Pharmacologic Agents in Kidney Disease.- 9. Prevention of Glomerular Damage with Pharmacologic Agents.- 10. Prognosis and Prevention of Renal Failure Induced by Toxins.- V. New Insights into Complications of Uremia.- 11. Functional Abnormalities of the Autonomic Nervous System in Uremic and Dialysis Patients.- 12. The Pathogenesis, Treatment, and Possible Prevention of Uremic Bone Disease.- VI. Uremia Therapy and the Long-Term Dialysis Patient: Natural History and Clinical, Psychological, and Economic Characteristics of the Over-Decade Frontier.- 13. Treatment of Chronic Renal Failure in Seattle: The First 20 Years.- 14. The Long Island College Hospital Experience with the Decade or Longer Hemodialysis Patient.- 15. Pathophysiology of Anephric Patients on Dialysis Over a Decade: Significance of Relative Hypotension.- 16. Cardiovascular Effects of a Decade or Longer of Mainteneance Hemodialysis: A Noninvasive Study.- 17. Over-Decade Maintenance Hemodialysis: Its Effect on Uremic Anemia and Coagulation.- 18. The Effects of Long-Term Hemodialysis on Gastrointestinal Function.- 19. Pulmonary Function and Arterial Blood Gas in the Long-Term Hemodialysis Patient.- 20. Musculoskeletal Abnormalities of the Ten-Year Hemodialysis Patient.- 21. NIH, Kidney Research, and the Patient with Renal Disease.- 22. Patients on Hemodialysis for Over Ten Years.- 23. Personality and Psychological Factors Influencing Survivorship on Hemodialysis.- VII. The Transplantation Alternative.- 24. Long-Term Survivors After Renal Transplantation.- 25. Brighter Outlook for Kidney Transplantation.- 26. Triggering Signals for T-Cell Activation in Renal Transplantation.- Author Index.
「Nielsen BookData」 より